Anja St Clair Jones
YOU?
Author Swipe
View article: Why local antibiotic resistance data matters – Informing empiric prescribing through local data collation, app design and engagement in Zambia
Why local antibiotic resistance data matters – Informing empiric prescribing through local data collation, app design and engagement in Zambia Open
Tools such as the free online ZARIApp can empower local settings to better understand and optimise how sampling and prescribing can help to improve patient care and reduce future AMR. However, the usability of the ZARIApp is severely limit…
View article: Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of <scp>UK IBD</scp> units and patients
Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of <span>UK IBD</span> units and patients Open
Summary Background Healthcare service provision in inflammatory bowel disease (IBD) is often designed to meet targets set by healthcare providers rather than those of patients. It is unclear whether this meets the needs of patients, as ass…
View article: P397 Can upskilling pharmacy technicians support a robust and cost-effective Inflammatory Bowel Disease patient review process? A single-centre prospective study
P397 Can upskilling pharmacy technicians support a robust and cost-effective Inflammatory Bowel Disease patient review process? A single-centre prospective study Open
Background Immunomodulators are key to the management of Inflammatory bowel disease (IBD). To ensure safety and efficacy, UK guidance recommend immunomodulator review. At University Hospitals Sussex (UHS), reviews are completed by a multi-…
View article: PMO-9 Reducing intravenous monoclonal antibody observation times without compromising patient safety; a single-centre observational study.
PMO-9 Reducing intravenous monoclonal antibody observation times without compromising patient safety; a single-centre observational study. Open
Introduction Monoclonal antibodies (MAbs) are integral to manage Inflammatory Bowel Disease (IBD). At Brighton & Sussex University Hospital, intravenous MAbs, infliximab and vedolizumab, are administered in an outpatient setting. Licensing…
View article: PWE-11 Can the online shopping model ‘lock-box delivery’ improve Hepatitis C treatment access amongst vulnerable adults?
PWE-11 Can the online shopping model ‘lock-box delivery’ improve Hepatitis C treatment access amongst vulnerable adults? Open
Introduction Hepatitis C virus (HCV) predominantly affects vulnerable and disenfranchised individuals, including people who use drugs (PWUD) and people who are homeless (PWAH); our prior work shows only 5% attend hospital appointments for …
View article: Antibiotic Prescribing Patterns in Ghana, Uganda, Zambia and Tanzania Hospitals: Results from the Global Point Prevalence Survey (G-PPS) on Antimicrobial Use and Stewardship Interventions Implemented
Antibiotic Prescribing Patterns in Ghana, Uganda, Zambia and Tanzania Hospitals: Results from the Global Point Prevalence Survey (G-PPS) on Antimicrobial Use and Stewardship Interventions Implemented Open
Antimicrobial resistance (AMR) remains an important global public health issue with antimicrobial misuse and overuse being one of the main drivers. The Global Point Prevalence Survey (G-PPS) of Antimicrobial Consumption and Resistance asse…
View article: Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing Open
This prospective service evaluation aimed to determine if integrated psychological support for patients with inflammatory bowel disease (IBD) enhanced outcomes. 75 patients were assessed and treated by a specialist liaison psychiatric serv…
View article: Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK
Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK Open
Objective Symptoms and clinical course during inflammatory bowel disease (IBD) vary among individuals. Personalised care is therefore essential to effective management, delivered by a strong patient-centred multidisciplinary team, working …
View article: UK and Zambian pharmacists: improving pharmacy practice, education and research by working together
UK and Zambian pharmacists: improving pharmacy practice, education and research by working together Open
View article: PWE-072 Pharmacy technician in the IBD team maintains patient safety whilst freeing up pharmacists and physicians
PWE-072 Pharmacy technician in the IBD team maintains patient safety whilst freeing up pharmacists and physicians Open
Introduction We previously demonstrated that incorporating a pharmacist into the Inflammatory Bowel Disease (IBD) team releases doctors' time and improves the consistency and safety of drug monitoring and counselling. We now take the next …
View article: PWE-094 Hepatitis-C information cards distributed through community pharmacies are ineffective in increasing HCV testing amongst PWID
PWE-094 Hepatitis-C information cards distributed through community pharmacies are ineffective in increasing HCV testing amongst PWID Open
Introduction Despite being a high risk group for hepatitis C virus (HCV) infection, People Who Inject Drugs (PWID) do not engage with health services. We present a low-cost intervention of issuing HCV information cards through community ph…
View article: P527 Infliximab biosimilar switching program overseen by specialist pharmacist saves money, realises investment and optimises therapy
P527 Infliximab biosimilar switching program overseen by specialist pharmacist saves money, realises investment and optimises therapy Open
Background: The parity of efficacy and safety of the biosimilar infliximab (IFX) has been demonstrated with data on switching still emerging. Specialist gastroenterology pharmacists are ideally placed to manage medicines optimisatio…